|
TRIO expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.306600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.877000E-01 |
| Normal-vs-Stage2 |
2.110000E-01 |
| Normal-vs-Stage3 |
1.221810E-01 |
| Normal-vs-Stage4 |
1.345800E-01 |
| Stage1-vs-Stage2 |
1.206400E-01 |
| Stage1-vs-Stage3 |
9.337600E-02 |
| Stage1-vs-Stage4 |
3.738800E-01 |
| Stage2-vs-Stage3 |
7.557400E-01 |
| Stage2-vs-Stage4 |
9.163700E-02 |
| Stage3-vs-Stage4 |
3.116200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.124000E-01 |
| Normal-vs-AfricanAmerican |
8.091000E-01 |
| Normal-vs-Asian |
2.040400E-01 |
| Caucasian-vs-AfricanAmerican |
6.925000E-01 |
| Caucasian-vs-Asian |
3.577000E-01 |
| AfricanAmerican-vs-Asian |
4.070200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.982200E-01 |
| Normal-vs-Female |
4.217700E-03 |
| Male-vs-Female |
8.978600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.533400E-01 |
| Normal-vs-Extreme_Weight |
3.592200E-01 |
| Normal-vs-Obese |
6.953700E-02 |
| Normal-vs-Extreme_Obese |
6.552100E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.072600E-01 |
| Normal_Weight-vs-Obese |
2.518400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.593600E-02 |
| Extreme_Weight-vs-Obese |
1.259700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.054000E-01 |
| Obese-vs-Extreme_Obese |
6.895200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.259600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.886000E-02 |
| Normal-vs-Age(61-80Yrs) |
5.381800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.444000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.257400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.636200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.045700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.919900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.227600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.244000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.322800E-01 |
| Normal-VS-Type2 PRCC |
6.985200E-01 |
| Normal-VS-KIRP CIMP |
1.868160E-01 |
| Normal-VS-Unclassified PRCC |
1.036260E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.379000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.116190E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.843200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.382600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.302000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.412600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.209000E-01 |
| Normal-vs-N1 |
1.081250E-01 |
| Normal-vs-N2 |
7.249600E-01 |
| N0-vs-N1 |
7.317900E-02 |
| N0-vs-N2 |
5.505600E-01 |
| N1-vs-N2 |
6.876200E-01 |
|
|
